Our Favorite Resources for
  • The Prostate Cancer Foundation funds high-impact research to find better treatments and a cure for prostate cancer.
    Prostate Cancer Foundation

  • The Prostate Net provides information on treatment options, research, news, support, and advocacy.
    The Prostate Net

More Resources

Prostate - More Stories

Mar 13, 2009

Supplements Offer No Prostate Cancer Protection

BY LENA HUANG

Selenium and vitamin E supplements get a negative grade in prevention test 

Dec 08, 2008

Finasteride Comes Out on Top in Prostate Cancer Trial

BY ELIZABETH WHITTINGTON

Trial confirms finasteride prevents prostate cancer. 

Oct 23, 2008

Preventing Prostate Cancer: Drugs or Diet?

BY ELIZABETH WHITTINGTON

Research focusing on early detection and prevention of prostate cancer with chemoprevention drugs such as Proscar and Avodart and dietary prevention with vitamins and supplements such as vitamin E and selenium.

Dec 10, 2007

Good to the Bone

BY PAUL ENGSTROM

Proactive strategy has patients taking preventive steps to protect their bones during therapy.

Sep 11, 2007

Q&A: Prostate Cancer Vaccine

BY LEN LICHTENFELD, MD

Why wasn’t Provenge approved? 

Sep 11, 2007

Prostate Cancer & MDS

BY ELIZABETH WHITTINGTON

Satraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends  survival in patients with MDS.

Jun 10, 2007

Surgeons and Robots

BY BEVERLY A. CALEY

Minimally invasive technologies transform the landscape of cancer surgery. 

Jun 10, 2007

Kidney Cancer & Prostate Cancer

BY ELIZABETH WHITTINGTON

The FDA approves third kidney cancer drug and blood-clotting therapy while delaying review on a prostate cancer vaccine, and one drug edges another in a colorectal cancer clinical trial.

Apr 08, 2007

Understanding ED

BY DON VAUGHAN

Causes of erectile dysfunction can vary, while treatment options abound.

Mar 15, 2007

Breast Cancer & Liver Cancer

BY ELIZABETH WHITTINGTON

An approval in breast cancer, positive clinical trial results in liver cancer, while a prostate cancer drug disappoints. 

PAGE : 1  2  3  4